[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342756-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342756-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identifying-tumor-type-and-cell-type-specific-gene-expression-alterations-in-pediatric-central-nervous-system-tumors","Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors","","Central nervous system (CNS) tumors are the leading cause of pediatric cancer death, yet their rarity has limited advances in targeted therapies. To address this gap, the study profiles single nuclei RNA-seq from 84,700 nuclei across 35 pediatric CNS tumors and three non-tumoral pediatric brain tissues. Tumor heterogeneity is characterized, and cell subpopulations linked to tumor types are identified. The work highlights neural stem cell-like pathways tied to therapy resistance and reports transcriptomic alterations between tumor and non-tumor tissues while accounting for cell type effects, suggesting tumor- and cell type-specific treatment targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identifying-tumor-type-and-cell-type-specific-gene-expression-alterations-in-pediatric-central-nervous-system-tumors/342756/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identifying-tumor-type-and-cell-type-specific-gene-expression-alterations-in-pediatric-central-nervous-system-tumors/342756.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data and sample types were used in the single-nucleus RNA-seq analysis?","Question",{"text":63,"@type":64},"The study collects single nuclei RNA-seq data from 84,700 nuclei across 35 pediatric CNS tumors and includes three non-tumoral pediatric brain tissue samples for comparison.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the study distinguish tumor-related cell subpopulations?",{"text":68,"@type":64},"It characterizes tumor heterogeneity and identifies cell subpopulations associated with specific tumor types, including radial glial cells in ependymomas and oligodendrocyte precursor cells in astrocytomas.",{"name":70,"@type":61,"acceptedAnswer":71},"What key pathways or findings are related to therapy resistance?",{"text":72,"@type":64},"The results observe pathways important in neural stem cell-like populations, a cell type previously associated with therapy resistance, and they interpret these as part of the tumor-specific transcriptional landscape.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342756,1790296746,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article [https://doi.org/10.1038/s41467-024-47712-8](https://doi.org/10.1038/s41467-024-47712-8)  \nIdentifying tumor type and cell type-speciﬁc gene expression alterations in pediatric central nervous system tumors  \nReceived: 18 February 2023  \n\n| Accepted: 9 April 2024 |\n| --- |\n| |\n| Check for updates |\n\nMin Kyung Lee 1, Nasim Azizgolshani1,2, Joshua A. Shapiro 3, Lananh N. Nguyen4, Fred W. Kolling 5, George J. Zanazzi5,6, Hildreth Robert Frost7 & Brock C. Christensen 1,8,9   \nCentral nervous system (CNS) tumors are the leading cause of pediatric cancer death, and these patients have an increased risk for developing secondary neoplasms. Due to the low prevalence of pediatric CNS tumors, major advances in targeted therapies have been lagging compared to other adult tumors. We collect single nuclei RNA-seq data from 84,700 nuclei of 35 pediatric CNS tumors and three non-tumoral pediatric brain tissues and characterize tumor heterogeneity and transcriptomic alterations. We distinguish cell subpopulations associated with speciﬁc tumor types including radial glial cells in ependymomas and oligodendrocyte precursor cells in astrocytomas. In tumors, we observe pathways important in neural stem cell-like populations, a cell type previously associated with therapy resistance. Lastly, we identify transcriptomic alterations among pediatric CNS tumor types compared to non-tumor tissues, while accounting for cell type effects on gene expression. Our results suggest potential tumor type and cell type-speciﬁc targets for pediatric CNS tumor treatment. Here we address current gaps in understanding single nuclei gene expression proﬁles of previously underinvestigated tumor types and enhance current knowledge of gene expression proﬁles of single cells of various pediatric CNS tumors.  \nCentral nervous system (CNS) tumors account for ~25% of pediatric cancer cases and are the leading cause of cancer death in children and adolescents in the United States1. However, CNS tumors in the pediatric population are rare in general, with 3.56 incidence per 100,000 for malignant tumors and 2.66 incidence per 100,000 for non-malignant tumors, which make these tumor types difﬁcult to investigate2. Incident pediatric CNS tumors are comprised of many histologically distinct tumor types including pilocytic astrocytomas (15.2%), embryonal  \ntumors (9.4%), and neuronal/mixed neuronal-glial tumors (7.9%)2. Survival rates vary widely among tumor types, with a good 10-year survival of 95.4% for pilocytic astrocytomas and a poor10-year survival of 15.9% for pediatric high-grade gliomas2. Pediatric CNS tumor patients are at risk of developing secondary neoplasms, with a 30-year cumulative incidence of malignant secondary neoplasms ranging from 4.7–7.8%3,4. The standard of care treatments for primary CNS tumors include surgery, radiotherapy, and chemotherapy with relatively  \n1Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. 2Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA. 3Childhood Cancer Data Lab, Alex’s Lemonade Stand Foundation, Bala Cynwyd, PA, USA. 4Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. 5Dartmouth Cancer Center, Lebanon, NH, USA. 6Department of Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. 7Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. 8Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. 9Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. e-mail: [Brock.Christensen@dartmouth.edu](Brock.Christensen@dartmouth.edu)  \nlimited options for targeted therapy compared to tumors in other anatomic regions.  \nRecent advances in identifying molecular subtypes in various pediatric CNS tumor types have been made utilizing genomic, transcriptomic a","cbCailyd1RHdQkxr","https://ap.wps.com/l/cbCailyd1RHdQkxr","pdf",2385984,14,"English","# Introduction\n## Pediatric CNS tumors: incidence, outcomes, and clinical need\n## Molecular subtypes and targeted therapy advances\n# Single-cell and single-nucleus transcriptomics\n## Prior single-cell studies and cellular hierarchies","[{\"question\":\"What data and sample types were used in the single-nucleus RNA-seq analysis?\",\"answer\":\"The study collects single nuclei RNA-seq data from 84,700 nuclei across 35 pediatric CNS tumors and includes three non-tumoral pediatric brain tissue samples for comparison.\"},{\"question\":\"How does the study distinguish tumor-related cell subpopulations?\",\"answer\":\"It characterizes tumor heterogeneity and identifies cell subpopulations associated with specific tumor types, including radial glial cells in ependymomas and oligodendrocyte precursor cells in astrocytomas.\"},{\"question\":\"What key pathways or findings are related to therapy resistance?\",\"answer\":\"The results observe pathways important in neural stem cell-like populations, a cell type previously associated with therapy resistance, and they interpret these as part of the tumor-specific transcriptional landscape.\"}]","Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors | PDF",1790048025,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb33145c290d719b8f1494ed9c2f0298.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c09cd9dbda65cc60b4d5c81ab53c27fc.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5532349e70408a2b35dd571e5b118bc3.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f9988013ec75bf30ba742f2081f3e27.webp",980,1301]